Indication for Nandrolone

Population group: Suitable for both men and women, only adults (18 years old or older)

For use in osteoporosis in post-menopausal women.

Established osteoporosis should have been diagnosed by the following parameters:

  • crush or wedge fractures of the vertebrae
  • other osteoporotic fractures
  • established reduction in bone mineral content as measured by accepted BMC measurements.

For this indication, competent medicine agencies globally authorize below treatments:

50 mg once every three weeks

Route of admnistration


Defined daily dose

50 - 50 mg

Dosage regimen

From 50 To 50 mg once every 21 day(s)

Detailed description

Post-menopausal women: 50mg every three weeks.

The duration of treatment depends on the clinical response and the possible occurrence of side-effects.

We would recommend that the effectiveness of therapy be monitored with the appropriate methods for osteoporosis on a 6-12 monthly basis.

Dosage considerations

It should be administered by deep intramuscular injection.

Active ingredient

Nandrolone is chemically related to testosterone and shows enhanced anabolic and a reduced androgenic activity. In humans nandrolone has been shown to positively influence calcium metabolism and to increase bone mass in osteoporosis.

Read more about Nandrolone

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner